Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tate & Lyle ( (GB:TATE) ) has shared an update.
Tate & Lyle has disclosed that non-executive director Claudia Vaz de Lestapis and a person closely associated with her, Alexandre Samuel Pierre Marie de Lestapis, purchased 5,000 American Depositary Receipts in the company on 6 January 2026 at a price of $19.79 per ADR on the OTCQX exchange. Following this transaction, they now hold 5,000 ADRs, representing 20,000 ordinary shares, a move formally notified under market abuse regulations that signals increased personal investment by a board member in the company’s equity.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £401.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Neutral.
Tate & Lyle’s overall stock score reflects stable financial performance and positive corporate events, such as insider share purchases. However, technical indicators and valuation suggest caution, with high P/E ratios and neutral momentum. Earnings call insights highlight current market challenges, balancing the positive aspects.
To see Spark’s full report on GB:TATE stock, click here.
More about Tate & Lyle
Tate & Lyle PLC is a UK-listed ingredients and food solutions company whose shares are also traded in the US via American Depositary Receipts (ADRs), each ADR representing four ordinary shares in the group. The company operates in global capital markets and is subject to regulatory disclosure requirements for insider and managerial dealings in its securities.
Average Trading Volume: 1,589,386
Technical Sentiment Signal: Sell
Current Market Cap: £1.62B
For an in-depth examination of TATE stock, go to TipRanks’ Overview page.